Roadmap for biomarker research on Alzheimer’s disease should lead to better results

Biomarkers could revolutionize the early detection of and therapy for Alzheimer’s disease. However, experts have criticized that the big breakthroughs are slow in coming because of a lack of priorities in research. A roadmap should help to push along advances in this area.